Does OMBITASVIR Cause Hyperbilirubinaemia? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Hyperbilirubinaemia have been filed in association with OMBITASVIR. This represents 11.2% of all adverse event reports for OMBITASVIR.
30
Reports of Hyperbilirubinaemia with OMBITASVIR
11.2%
of all OMBITASVIR reports
2
Deaths
5
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From OMBITASVIR?
Of the 30 reports, 2 (6.7%) resulted in death, 5 (16.7%) required hospitalization, and 1 (3.3%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMBITASVIR. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does OMBITASVIR Cause?
Anaemia (39)
Fatigue (34)
Drug interaction (24)
Headache (21)
Hepatitis c (21)
Nausea (21)
Insomnia (19)
Hepatic failure (17)
Alanine aminotransferase increased (16)
Hepatocellular carcinoma (16)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which OMBITASVIR Alternatives Have Lower Hyperbilirubinaemia Risk?
OMBITASVIR vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMBITASVIR vs OMEGA-3-ACID ETHYL ESTERS
OMBITASVIR vs OMEGA-3-CARBOXYLIC ACIDS
OMBITASVIR vs OMEGA-3 FATTY ACIDS
OMBITASVIR vs OMEPRAZOLE